134 related articles for article (PubMed ID: 6361168)
1. KF-1 monoclonal antibody defines a specific basement membrane antigen defect in dystrophic forms of epidermolysis bullosa.
Fine JD; Breathnach SM; Hintner H; Katz SI
J Invest Dermatol; 1984 Jan; 82(1):35-8. PubMed ID: 6361168
[TBL] [Abstract][Full Text] [Related]
2. Epidermolysis bullosa: variability of expression of cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens in clinically uninvolved skin.
Fine JD
J Invest Dermatol; 1985 Jul; 85(1):47-9. PubMed ID: 3891876
[TBL] [Abstract][Full Text] [Related]
3. LDA-1 monoclonal antibody. An excellent reagent for immunofluorescence mapping studies in patients with epidermolysis bullosa.
Fine JD; Gay S
Arch Dermatol; 1986 Jan; 122(1):48-51. PubMed ID: 3510588
[TBL] [Abstract][Full Text] [Related]
4. 19-DEJ-1, a hemidesmosome-anchoring filament complex-associated monoclonal antibody. Definition of a new skin basement membrane antigenic defect in junctional and dystrophic epidermolysis bullosa.
Fine JD; Horiguchi Y; Couchman JR
Arch Dermatol; 1989 Apr; 125(4):520-3. PubMed ID: 2649012
[TBL] [Abstract][Full Text] [Related]
5. The epidermal basement membrane: structure, ontogeny and role in disease.
Katz SI
Ciba Found Symp; 1984; 108():243-59. PubMed ID: 6394239
[TBL] [Abstract][Full Text] [Related]
6. The epidermal basement membrane zone--structure, ontogeny, and role in disease.
Katz SI
J Am Acad Dermatol; 1984 Dec; 11(6):1025-37. PubMed ID: 6512049
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to extracellular collagen matrix components in epidermolysis bullosa and other bullous diseases.
Gay S; Fine JD; Storer JS
Arch Dermatol Res; 1988; 280(6):333-7. PubMed ID: 3056284
[TBL] [Abstract][Full Text] [Related]
8. Altered skin basement membrane antigenicity in epidermolysis bullosa.
Fine JD
Curr Probl Dermatol; 1987; 17():111-26. PubMed ID: 3297501
[No Abstract] [Full Text] [Related]
9. Abnormal binding of an anti-amnion antibody to epidermal basement membrane provides a novel diagnostic probe for junctional epidermolysis bullosa.
Kennedy AR; Heagerty AH; Ortonne JP; Hsi BL; Yeh CJ; Eady RA
Br J Dermatol; 1985 Dec; 113(6):651-9. PubMed ID: 3913455
[TBL] [Abstract][Full Text] [Related]
10. A unique epithelial basement membrane antigen defined by a monoclonal antibody (KF-1).
Breathnach SM; Fox PA; Neises GR; Stanley JR; Katz SI
J Invest Dermatol; 1983 May; 80(5):392-5. PubMed ID: 6341473
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis of dominant and recessive dystrophic epidermolysis bullosa: application and limitations in the use of KF-1 and LH 7:2 monoclonal antibodies and immunofluorescence mapping technique.
Fine JD; Eady RA; Levy ML; Hejtmancik JF; Courtney KB; Carpenter RJ; Holbrook KA; Hawkins HK
J Invest Dermatol; 1988 Nov; 91(5):465-71. PubMed ID: 3049834
[TBL] [Abstract][Full Text] [Related]
12. Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid).
Briggaman RA; Gammon WR; Woodley DT
J Invest Dermatol; 1985 Jul; 85(1 Suppl):79s-84s. PubMed ID: 4008982
[TBL] [Abstract][Full Text] [Related]
13. The appearance of four basement membrane zone antigens in developing human fetal skin.
Fine JD; Smith LT; Holbrook KA; Katz SI
J Invest Dermatol; 1984 Jul; 83(1):66-9. PubMed ID: 6376641
[TBL] [Abstract][Full Text] [Related]
14. Identification of an epidermal basement membrane defect in recessive forms of dystrophic epidermolysis bullosa by LH 7:2 monoclonal antibody: use in diagnosis.
Heagerty AH; Kennedy AR; Leigh IM; Purkis P; Eady RA
Br J Dermatol; 1986 Aug; 115(2):125-31. PubMed ID: 3527251
[TBL] [Abstract][Full Text] [Related]
15. Immunofluorescence mapping of antigenic determinants within the dermal-epidermal junction in the mechanobullous diseases.
Hintner H; Stingl G; Schuler G; Fritsch P; Stanley J; Katz S; Wolff K
J Invest Dermatol; 1981 Feb; 76(2):113-8. PubMed ID: 6161971
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to basement membrane collagen: epidermolysis bullosa simplex versus bullous pemphigoid.
Gay S; Ward WQ; Gay RE; Miller EJ
J Cutan Pathol; 1980 Oct; 7(5):315-7. PubMed ID: 7000866
[TBL] [Abstract][Full Text] [Related]
17. Basement membrane reactivity of antisera to type IV collagen and sera from patients with bullous pemphigoid and epidermolysis bullosa acquisita.
Peng TK; Nisengard RJ; Levine MJ; Beutner EH
Proc Natl Sci Counc Repub China B; 1984 Jul; 8(3):268-73. PubMed ID: 6400590
[TBL] [Abstract][Full Text] [Related]
18. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita.
Woodley DT; Briggaman RA; O'Keefe EJ; Inman AO; Queen LL; Gammon WR
N Engl J Med; 1984 Apr; 310(16):1007-13. PubMed ID: 6369131
[TBL] [Abstract][Full Text] [Related]
19. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods.
Gammon WR; Inman AO; Wheeler CE
J Invest Dermatol; 1984 Jul; 83(1):57-61. PubMed ID: 6376640
[TBL] [Abstract][Full Text] [Related]
20. Anatomical distribution and immunological characteristics of epidermolysis bullosa acquisita antigen and bullous pemphigoid antigen.
Furue M; Iwata M; Tamaki K; Ishibashi Y
Br J Dermatol; 1986 Jun; 114(6):651-9. PubMed ID: 3521710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
